Back to Search Start Over

Comprehending fibroblast growth factor receptor like 1: Oncogene or tumor suppressor?

Authors :
Aprajita
Rinu Sharma
Source :
Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100472- (2021)
Publication Year :
2021
Publisher :
Elsevier, 2021.

Abstract

Fibroblast Growth Factor Receptor Like 1 (FGFRL1) signaling has crucial role in a multitude of processes during genetic diseases, embryonic development and various types of cancer. Due to its partial structural similarity with its classical Fibroblast Growth Factor Receptor [FGFR] counterparts and lack of tyrosine kinase domain, FGFRL1 was thought to work as a decoy receptor in FGF/FGFR signaling. Later on, growing number evidences showed that expression of FGFRL1 affects major pathways like ERK1/2, Akt and others, which are dysfunctional in a wide range of human cancers. In this review, we provide an overview of the current understanding of FGFRL1 and its roles in cell differentiation, adhesion and proliferation pathways . Overexpression of FGFRL1 might lead to tumor progression and invasion. In this context, inhibitors for FGFRL1 might have therapeutic benefits in human cancer prognosis.

Details

Language :
English
ISSN :
24682942
Volume :
29
Issue :
100472-
Database :
Directory of Open Access Journals
Journal :
Cancer Treatment and Research Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.106ea49814a746fcbe1be8404c2ffb3c
Document Type :
article
Full Text :
https://doi.org/10.1016/j.ctarc.2021.100472